Conference Coverage

Undiagnosed prediabetes pervasive among stroke survivors


 

AT THE INTERNATIONAL STROKE CONFERENCE

One in three stroke survivors in the United States has undiagnosed prediabetes, a national survey has shown.

Black stroke survivors are more than twice as likely as whites to have undiagnosed prediabetes or diabetes mellitus, while Hispanics have an intermediate risk, Dr. Amytis Towfighi said at the International Stroke Conference sponsored by the American Heart Association.

Amytis Towfighi

She presented an analysis of 1,070 adult stroke survivors included in the National Health and Nutrition Examination Survey, a Centers for Disease Control and Prevention–sponsored cross-sectional survey weighted so as to be representative of the full U.S. population. Thus, the findings in the NHANES stroke survivors can be extrapolated to the estimated 5.1 million adult stroke survivors nationwide.

The overall prevalence of prediabetes among stroke survivors as defined by a hemoglobin A1c level of 5.7%-6.4% was 32.3%. The figure was 37.8% in blacks, 31.6% in Hispanics, and 26.3% in whites. Only 2.5% of stroke survivors had physician-diagnosed prediabetes, reported Dr. Towfighi, who is chair of the neurology department and director of the acute neurology and acute stroke unit at Rancho Los Amigos National Rehabilitation Center, Downey, Calif.

The prevalence of undiagnosed diabetes mellitus was 3.7% overall. In contrast, 26.9% of stroke survivors had diagnosed diabetes, with rates ranging from 42.7% in Hispanics to 35.7% in blacks and 24.4% in whites.

Black stroke survivors with undiagnosed prediabetes or diabetes were significantly younger: a mean of 59 years old compared with 70 years in whites and 67 years in Hispanics. They were also significantly more likely to smoke and to be on antihypertensive medications. Of black stroke survivors, 58% were women compared with 42% of white stroke survivors.

Chronic hyperglycemia is a potent risk factor for vascular events. Thus, unrecognized prediabetes or diabetes may amplify an individual’s risk of recurrent stroke. Given that if left untreated, prediabetes will progress to diabetes, it makes sense to systematically screen patients for these metabolic abnormalities at the time of an index stroke as a means of improving clinical outcomes and reducing racial disparities, Dr. Towfighi said.

She reported having no relevant financial conflicts.

b.jancin@elsevier.com

Recommended Reading

Novel hemorrhagic stroke therapy bests medical management
MDedge Family Medicine
FDA withholds insulin degludec approval; wants safety data
MDedge Family Medicine
Aggressive BP lowering after lacunar stroke may reduce recurrence
MDedge Family Medicine
Critics dub JNC-8 as 'JNC-Late'
MDedge Family Medicine
Apixaban, dabigatran found effective, safe for extended post-VTE therapy
MDedge Family Medicine
Cardiac stress testing underutilized in stroke patients
MDedge Family Medicine
Poor outcomes seen after carotid intervention non-ST-elevation MI
MDedge Family Medicine
Pooled data allow fine-tuning of surveillance intervals for AAA
MDedge Family Medicine
Aldo-DHF published: Spironolactone aids LV function but not symptoms
MDedge Family Medicine
Atrial fibrillation device among top trials at ACC 13
MDedge Family Medicine